Search
for
Sort by
Research 841–870 of 1000+
- Dermatologic manifestations of endocrine disorders
- Green tea: Health benefits
- Drug Reactions Affecting Hair: Diagnosis
- PAK4 signaling in health and disease: defining the PAK4–CREB axis
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies
- Clinical and biological impact of the exposome on the skin
- Adverse effects of common medications on male fertility
- Methotrexate in dermatology
- YAP and TAZ are essential for basal and squamous cell carcinoma initiation
- Template for Skin Regeneration
- Management of Hair Loss
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Physiological and biological skin changes in pregnancy
- Beyond Expectations
- Replicative stress, stem cells and aging
- Oestrogen functions in skin and skin appendages
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Mechanical forces in skin disorders
- Emerging nonmetabolic functions of skin fat
- Primary cicatricial alopecia
- The incidence of diplopia following coronal and translid orbital decompression in Graves' orbitopathy
- PHYSIOLOGIC SKIN CHANGES ASSOCIATED WITH PREGNANCY
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- DRUG‐ASSOCIATED ALOPECIA
- Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor